Okay but if + 2m of TCV is fluff....Many stocks would kill for this type of growth so rapidly
Under regulation this HAS to be reported anyway
MOUs have been announced all year, and the SP was low because the only thing missing was revenue
Now all of a sudden we are seeing money rolling in off a well-run company, and you have an issue with it....yet you hold....does not make sense
- Forums
- ASX - By Stock
- VR1
- Ann: Vection TCV Growth Outperforms First Half Objective
Ann: Vection TCV Growth Outperforms First Half Objective, page-44
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.40M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $4.21K | 221.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25856 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 230485 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25856 | 0.019 |
8 | 1049882 | 0.018 |
2 | 455000 | 0.017 |
4 | 587500 | 0.016 |
4 | 624000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 230485 | 5 |
0.021 | 1243220 | 11 |
0.022 | 940554 | 7 |
0.023 | 449310 | 1 |
0.024 | 586701 | 6 |
Last trade - 11.44am 16/07/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online